Bookmark and Share

Last Minute: "Texas: Accused San Antonio migrant lorry driver was pretending to be survivor when arrested, police say - Sky News" Thu, 30 Jun 2022 03:38:20 GMT    "Family of Captain Sir Tom Moore face formal inquiry into charity setup - The Guardian" Thu, 30 Jun 2022 09:03:00 GMT    "Meghan Markle: Outcome of palace inquiry into how ?bullying? claims handled to be kept secret - The Independent" Thu, 30 Jun 2022 08:00:20 GMT    "Russian forces retreat from Snake Island, defence ministry says - The Independent" Thu, 30 Jun 2022 10:11:18 GMT    "Mother fatally shot 'at point-blank range' while pushing baby in pram in New York City - Sky News" Thu, 30 Jun 2022 06:51:18 GMT    "Six police forces in England placed in special measures - BBC" Thu, 30 Jun 2022 10:01:22 GMT    "Flights cancelled from Heathrow due to 'higher passenger numbers than airport can serve' - Sky News" Thu, 30 Jun 2022 09:56:15 GMT    "Home Office dragged to High Court by Brexit deal watchdog over ?unlawful? treatment of EU citizens - The Independent" Thu, 30 Jun 2022 09:32:06 GMT    "Former SNP MP jailed for embezzling £25,000 - The Guardian" Thu, 30 Jun 2022 10:04:00 GMT   "Liz Truss defends plans to cut British army by nearly 10,000 troops - The Guardian" Thu, 30 Jun 2022 09:05:00 GMT      For more news, click here.

Remember me? 

PS: The quotes after 2018-12-03 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Gilead Sciences Static Chart

Fall of
--0.39 (+0.99%) Gilead Sciences - [Ticker: GILD]Chart Gilead Sciences  News Gilead Sciences  Download Historical Prices for Metastock Gilead Sciences and Others  Technical Analysis Gilead Sciences  
Last Trade71.55Last Trade Time2018-12-03 - 00:00:00
Variation--0.39 (+0.99%)Open72.74
Volume2,159,096Average Volume (3m)0
YieldBid / Ask74.80 x 800 - 74.82 x 1,000
Former Close71.9452 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about Gilead Sciences [GILD]:   (ordered by relevance)
Gilead Endorses The Kigali Declaration On Preventing, Controlling and Eliminating Neglected Tropical Diseases  Gilead Sciences Gilead Sciences Appoints Stacey Ma, PhD as Executive Vice President, Pharmaceutical Development and Manufacturing  Gilead Sciences Remdesivir Covid-19 Market Size Latest Research Report| Gilead Sciences, Inovio Pharmaceuticals, Kelun Pharma ? Designer Women  Designer Women Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress? 2022  Gilead Sciences Gilead Sciences: Buy The Dip (NASDAQ:GILD)  Seeking Alpha Gilead tries again with twice-yearly HIV drug lenacapavir -  pharmaphorum Westminster Drug Project and Gilead Sciences join forces to take on hepatitis C  PharmaTimes Kite's CAR T-cell Therapy Yescarta® Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Follicular Lymphoma  Gilead Sciences Gilead Sciences Inc. stock outperforms competitors on strong trading day  MarketWatch All Magrolimab Studies Re-Opening for Enrollment in US | Gilead  Gilead Sciences Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Rothschild Investment Corp IL  Defense World Up-Inhaled Antibiotics Market Size, Scope and Forecast | Gilead Sciences, Aradigm, Lupin Ltd. Polyphor, Joincare Pharmaceutical Group, Pharmaxis Ltd and Savara Pharmaceuticals. ? Designer Women  Designer Women Oncology: Market 2022 Is Booming Worldwide | Gilead Sciences, Bristol Myers Squibb, Novartis, Pfizer ? Designer Women  Designer Women Liposome Drug Delivery Market 2022 | Detailed Report- Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma ? Designer Women  Designer Women CSRWire - Gilead Sciences Inaugural Data Science Symposium Global AmBisome Market 2022 Industry Insights and Key Players like Gilead Sciences, Cipla ? Designer Women  Designer Women Gilead, Sanofi, GSK and more to pay for employees' abortion-related travel costs after Roe ruling  FiercePharma Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity  Gilead Sciences Global Liposomal Amphoteracin B Market Forecast (2022-2028) Top Manufacturers: Gilead Sciences, Cipla ? Designer Women  Designer Women Gilead Sciences, Inc. (GILD) Management presents at Bernstein 38th Annual Strategic Decisions Conference - Transcript  Seeking Alpha Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of ?Hold? by Brokerages  Defense World Gilead drug cuts disease progression in commonest type of breast cancer (NASDAQ:GILD)  Seeking Alpha Gilead: CAR-T future is both auto and allo - Bioprocess Insider  BioProcess Insider Gilead Sciences, Inc. (GILD) CEO Dan O'Day Presents at Goldman Sachs Global Healthcare Conference (Transcript)  Seeking Alpha Gilead Sciences, Inc. (GILD) Management Presents at Jefferies Global Healthcare Conference - (Transcript)  Seeking Alpha Gilead launches domestic products to local market  Hurriyet Daily News Gilead Sciences goes ex-dividend tomorrow  Seeking Alpha Gilead (GILD) Announces Positive Data on Hepcludex for HDV  Nasdaq Pharmaceutical Drugs Market 2022 Booming Strategies of Top Companies ? AstraZeneca, Gilead Sciences, Johnson and Johnson, GlaxoSmithKline (GSK), Takeda, Boehringer Ingelheim, Allergan ? Designer Women  Designer Women Infectious Diseases Market to Witness Robust Expansion by 2029 | F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline ? Designer Women  Designer Women Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Raised by CAPROCK Group Inc.  Defense World Takeda Pharmaceutical Vs. Gilead Sciences: Which Stock Is The Dividend King?  Seeking Alpha Gilead Sciences Inc. stock falls Thursday, underperforms market  MarketWatch Global Sterile Injection Market Competition Challenges 2022-2029 | GlaxoSmithKline, Gilead Sciences, Baxter International ? Designer Women  Designer Women Gilead wins suit over patient assistance program's 'colossal financial fraud'  STAT Gilead (GILD) HIV Candidate Gets Positive CHMP Recommendation  Zacks Investment Research Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size And Forecast to 2028 |AstraZeneca, Concordia International, Gilead Sciences, Merck, Mylan ? Designer Women  Designer Women Providing Support for Women with Breast Cancer  Gilead Sciences Gilead Sciences (GILD) Stock Moves -0.99%: What You Should Know  Yahoo Finance HIV Vaccines Market Size, Scope and Forecast | VIIV healthcare, Gilead Sciences, Inc, GlaxoSmithKline plc, Merck Sharp & Dohme Corp., AbbVie Inc, Mylan NV, and many more. ? Designer Women  Designer Women CSRWire - Gilead Leadership Organization of Black Employees (GLOBE) Raised the Juneteenth Flag Liposomal DDS Technology Market Is Expected to Boom | Gilead Sciences, Pacira, Sun Pharmaceutical ? Indian Defence News  Indian Defence News CAGR +23.0% , Antibody Drug Conjugate Market to reach USD 18.31 billion by 2027 | Gilead Sciences, Inc., Astellas Pharma, Seagen, Inc. ? Designer Women  Designer Women Anti-Infective Drugs Market Size, Scope and Forecast | Gilead Sciences GlaxoSmithKline plc, Pfizer Novartis AG, Merck, Bayer AG, Others. ? Designer Women  Designer Women Immunocell Therapy Market Future Scope including key players Gilead Sciences, Novartis ? Designer Women  Designer Women Gilead Stock: Future In Three Molecules (NASDAQ:GILD)  Seeking Alpha ASCO: Can Gilead, Pfizer and AZ-Daiichi change breast cancer?  FiercePharma Gilead Sciences expands regional footprint with new Dubai office  ZAWYA Gene Therapy Market Size, Scope and Forecast | Novartis AG, Biogen, Gilead Sciences MolMed SpA, Spark Therapeutics Orchard Therapeutics plc., SIBIONO, Bluebird bio Shanghai Sunway Biotech Co. Ltd., Human Stem Cells Institute. ? Designer Women  Designer Women Sterile Injectables Market Growth and Changes Influencing the Industry 2030 | Pfizer, Baxer International, Glaxo smith kline, Novartis, Gilead Sciences ? Designer Women  Designer Women Prophylactic HIV Drug Market 2022 Share, Size, Global Industry Analysis, Trends, Growth And Forecast 2028 | Gilead Sciences, Merck, Mylan ? Designer Women  Designer Women BMS cancer drug's expanded approval gives it an edge over a Gilead cell therapy  MedCity News Antiretroviral Drugs Market Report One Research Solution Reveal Everything You Need to Know About Key Players | Gilead Sciences Inc., ViiV Healthcare, Bristol-Myers Squibb, AbbVie Inc., Boehringer Ingelheim, Johnson & Johnson ? Designer Women  Designer Women The 15 highest-paid biopharma CEOs of 2021  FiercePharma Global Gene Therapy On Cardiovascular Disease Market 2022 Industry Overview by Top Players ? Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics ? Designer Women  Designer Women Global Cell-Based Immunotherapy Market Recent Investment and Regional Forecast 2022-2029 | Gilead Sciences, AbbVie, Bristol-Myers Squibb ? Designer Women  Designer Women Global Hepatitis B Virus Treatment Market Share 2022 | Merck and Co, Gilead Sciences, Novartis AG, GlaxoSmithKline ? Designer Women  Designer Women New eczema meds from AbbVie, Pfizer and Leo Pharma score NICE backing  FiercePharma Global Oral Solid Dosage Pharmaceutical Formulation Market discussed in a new research report Gilead Sciences, Merck & Co., Novartis, Pfizer ? Designer Women  Designer Women Head to Head Contrast: Surrozen (NASDAQ:SRZN) vs. Gilead Sciences (NASDAQ:GILD)  Defense World Regenerative Medicine Market Share, Demand and Growth by Business Development to 2030 | Gilead Sciences, Novartis, Spark Therapeutics, Orchard Therapeutics, MolMed, Celgene, Sanofi, Amgen ? Designer Women  Designer Women Liver Diseases Therapeutics Market Size, Scope and Forecast | Astellas Pharma Inc., Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Novartis AG, Alnylam Pharmaceuticals Protagonist Therapeuti  Designer Women ViiV, Gilead and Janssen notch top scores with HIV/AIDS groups  FiercePharma Excellent Growth of Nano-drug Market 2022 | Merck, Pfizer, Novartis, etc. ? Designer Women  Designer Women Liver Fibrosis Treatment Market 2022-2030 [PDF] Future and Development | Johnson and Johnson, Gilead Sciences, Merck & Co., Bristol-Myers Squibb  Digital Journal Nanopharmaceutical Drugs Market Outlook 2022 And Growth By Top KeyPlayers ? Pfizer, Merck, AstraZeneca, Gilead Sciences ? Designer Women  Designer Women Global Oral and Topical Anaesthetics Market 2022 COVID-19 Impact Analysis and Top Companies as Aspen Pharmacare, Septodont, Dentsply Sirona, Gilead Sciences ? Designer Women  Designer Women Which Biotech Stock is the Street More Bullish on?  Nasdaq Cutaneous Leishmaniasis Drugs Market Biggest Innovation with Top Key Players -GSK, Novartis, Sanofi, Gilead Sciences, Bristol-Myers Squibb, Albert David, Profounda, Knight Therapeutics, Pfizer, Xinhua Pharma ? Indian Defence News  Indian Defence News Biocom California Adds to its Board of Governors Veriti Management LLC Has $897000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)  Defense World Zika Vaccines Market Size, Scope and Forecast | Inovio Pharmaceuticals Emergent BioSolutions Inc., Gilead Sciences Inc., Precigen LUMOS PHARMA, Hawaii Biotech Inc., Sanofi, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Bharat Biotec  Designer Women Sickle Cell Disease Treatment Market Size, Scope and Forecast | Pfizer Inc., Eli Lilly, Merck & Co Inc, Novartis AG, Sanofi, Baxter, Bristol-Myers Squibb Company, Bluebird Bio, Gilead Sciences, Global Blood Therapeutics ? Designer Women  Designer Women Next-Generation HIV therapies Market is Booming Worldwide with ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline plc, Merck Sharp & Dohme Corp.  Digital Journal Parkinsons Disease Drugs Market Overview 2022-2030: What will Drive the Huge ROI by Size, Demand, Growth and Forecast | Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical ? Indian Defence News  Indian Defence News Sanofi cuts insulin price for uninsured in US from $99 to $35  FiercePharma Chimeric Antigen Receptor (CAR)-T Treatment Market SWOT Analysis of Top Key Player Forecasts to 2028| Novartis AG, Gilead Sciences, Inc, AbbVie Inc, Adaptimmune, Amgen Inc, Atara Biotherapeutics, Aurora Biopharma, Autolus ? Designer Women  Designer Women NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Development Size 2022 |GENFIT SA, Gilead Sciences, Inc. (GILD), AstraZeneca, Novartis AG, Bristol-Myers Squibb Company, Allergan Plc, Novo Nordisk A/S, Boehringer Ingelheim, Pfizer Inc ? Indian  Indian Defence News Global Ambrisentan Market Current and Future Growth Analysis 2022-2029 Megafine, Yichang Tianren Pharmaceutical, Confucius Pharmceutical, Gilead Sciences ? Designer Women  Designer Women GILEAD SCIENCES NEW DATA HIGHLIGHTS PEOPLE LIVING WITH HIV WHO ARE VIRALLY SUPPRESSED EXPERIENCE SIMILAR HEALTH-RELATED QUALITY OF LIFE AS GENERAL POPULATION  AsiaOne 2 Beaten-Down Dividend Stocks That Are Now Yielding 5%  The Motley Fool Cutaneous B-Cell Lymphoma Treatment Market Research With Gilead Sciences, Roche, Novartis, Epizyme, NanoString Technologies | 2022 Report ? Indian Defence News  Indian Defence News Gilead Sciences Announces First Quarter 2022 Financial Results  Gilead Sciences Volume turns up on Decibel as hearing loss therapy protects patients in early-stage trial  FiercePharma Former biopharmaceutical corporate comms chief pleads guilty to insider trading  PR Week Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results  Gilead Sciences Antiviral Drugs Market Size | Potential Growth, Attractive Valuation Make It Is A Long-Term Investment By Forecast 2022-2028 ? Designer Women  Designer Women Planning all-oral, once-daily regimen, J&J gets EMA backing for Imbruvica-venetoclax combination  FiercePharma Atrial Fibrillation Drugs Market Size, Scope and Forecast | ARCA Biopharma, Baxter International Inc., Bristol-Myers Squibb, Gilead Sciences, HUYA Biosciences, Janssen Pharmaceuticals, Pfizer Inc., Pierre Fabre, Servier, Xention Ltd. ? Designer Women  Designer Women With SPAC merger looming, Scilex sues Apotex to block generic copy of key pain patch  FiercePharma PD-1 And PD-L1 Inhibitors Market Size, Scope and Forecast | Bristol-Myers Squibb, Merck & Co., F. Hoffmann-La Roche AG, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Celgene ? Designer Women  Designer Women Medication Market 2022 Insights and Precise Outlook ? Pfizer, Roche, Sanofi, Johnson & Johnson, ? Designer Women  Designer Women Gilead Sciences to Release First Quarter 2022 Financial Results on Thursday, April 28, 2022  Gilead Sciences Gilead Sciences to Present at Upcoming Investor Conferences  Gilead Sciences Gilead Sciences Announces 2.8 Percent Increase in First Quarter 2022 Dividend  Gilead Sciences Gilead Receives Complete Response Letter From US FDA for Investigational Lenacapavir Due to Vial Compatibility Issues  Gilead Sciences Gilead Statement on U.S. Supreme Court Overturning Roe v. Wade  Yahoo Finance Thrombocythaemia Myelofibrosis Treatment Market Size 2022 Industry Recent Developments and Technology, Size, Trends, Growth, and Forecast Research Report 2029 ?Celgene Corporation, Gilead Sciences, Inc., Incyte Corporation, JW Pharmaceutical C  Indian Defence News Gilead Sciences Announces $24 Million in Grants to Help End the HIV Epidemic for Everyone, Everywhere  Gilead Sciences Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report  Gilead Sciences
For more news about Gilead Sciences click here:
Gilead Sciences News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources